Is EFAV a Buy? What to Consider in 2026
Last updated July 2026
Short answer
The case for EFAV is simple: low-cost, diversified exposure to a developed-markets ex-US equity index at a 0.20% expense ratio, anchored by names like , , . If that is the exposure you want and you do not already own most of it through another fund, EFAV is a strong core holding. The catch is concentration in its top names and overlap with broad-market funds you may already hold. Whether it is a buy comes down to whether you want a developed-markets ex-US equity index and at what cost. Not a recommendation; Walnut is not an investment adviser.
What are you buying with EFAV?
EFAV tracks a developed-markets ex-US equity index. It charges 0.20%. It yields about 3.26%, enough that income is part of the reason people hold it. It launched in 2011. Holdings are spread widely, with the ten largest coming to about 14% of assets.
Largest holdings (approximate as of August 2026; verify on iShares's fund page):
| Rank | Ticker | Company | % of EFAV | |
|---|---|---|---|---|
| 1 | Iberdrola SA | 1.7% | ||
| 2 | SECOM Co Ltd | 1.5% | ||
| 3 | Novartis AG Registered Shares | 1.5% | ||
| 4 | Zurich Insurance Group AG | 1.4% | ||
| 5 | Takeda Pharmaceutical Co Ltd | 1.4% | ||
| 6 | DBS Group Holdings Ltd | 1.4% | ||
| 7 | Shell PLC | 1.4% | ||
| 8 | Swisscom AG | 1.3% | ||
| 9 | Eni SpA | 1.3% | ||
| 10 | TotalEnergies SE | 1.3% |
What's the case for EFAV?
Developed-markets ex-US equities in a single iShares fund, at 0.20%.
In its favour: it gives you a developed-markets ex-US equity index exposure in one ticker at a 0.20% expense ratio, which is simple to hold and cheap to own.
What should you weigh before buying EFAV?
- Cost vs alternatives: 0.20% is the fee; compare it to funds tracking a similar index.
- Concentration: check how much of EFAV sits in its largest holdings (, , ).
- Overlap: if you already own a broad-market fund, you may already hold much of this.
- Tracking scope: EFAV only gives you a developed-markets ex-US equity index; it will not capture what sits outside that index.
How do you decide if EFAV is a buy?
The useful question is rarely “will EFAV go up?” It is “does this exposure fit my plan, at a cost I am happy with, without doubling up on what I already own?” Walnut connects your real brokerage so you can see exactly how EFAV would overlap with your current holdings, analyze it by chatting through Claude or ChatGPT, and place any trade yourself. You stay in control.
The bottom line on EFAV
The bottom line: EFAV is a low-cost core building block for a developed-markets ex-US equity index exposure, not a tactical bet on a single name. If you want a developed-markets ex-US equity index exposure and the 0.20% fee is competitive for you, it does its job well. If you already own that exposure through another fund, adding it mostly doubles a fee without adding diversification. Decide from your goal and your existing holdings, not from where the market sat last week. Walnut is not an investment adviser.
More on EFAV
- What is EFAV? (holdings, cost, performance, and the themes it covers)
- EFAV dividend: yield and schedule
Investing in EFAV with AI
Connect the broker you already use and ask Walnut's AI how EFAV fits what you actually hold: what it overlaps with, what it leaves you exposed to, and how it has tracked the S&P 500. Read-only by default, and you approve anything before it reaches your broker.
FAQ
Is EFAV a good ETF to buy?
+
Walnut is informational, not investment advice. Whether EFAV fits depends on your goals, time horizon, and what you already hold. It tracks a developed-markets ex-US equity index at a 0.20% expense ratio, so the questions that matter are whether you want that exposure, whether you already own it through another fund, and whether the cost is competitive for what it does.
What does EFAV actually hold?
+
EFAV tracks a developed-markets ex-US equity index. Its largest positions include , , , , and others (approximate, verify on iShares's fund page). The holdings are what you are really buying, not the ticker.
What is EFAV's expense ratio?
+
0.20% as of August 2026. Over decades, the expense ratio is one of the few things you can control, so it is worth comparing against close alternatives that track a similar index.
Does EFAV pay a dividend?
+
EFAV distributes a dividend with an approximate yield of 3.26% (August 2026). See the EFAV dividend page for how distributions work. Verify the current figure with iShares.
What are the risks of buying EFAV?
+
Like any index ETF, weigh concentration (how much sits in the top holdings), overlap with funds you already own, and whether a developed-markets ex-US equity index matches the exposure you actually want. EFAV only gives you a developed-markets ex-US equity index, not what sits outside it.
How do I decide if EFAV is right for me?
+
Start from your goal, then check four things: what EFAV holds, its cost versus alternatives, how much it overlaps with what you already own, and whether the exposure fits your time horizon and risk tolerance. Walnut can analyze the overlap against your real holdings; you keep your broker and approve any trade.
Walnut is informational, not investment advice. Figures are approximations stamped to August 2026; verify current data with iShares or your broker. Nothing here is a recommendation to buy, sell, or hold any security.